2019
DOI: 10.1038/s41536-019-0070-y
|View full text |Cite
|
Sign up to set email alerts
|

Proteomic analysis of human mesenchymal stromal cell secretomes: a systematic comparison of the angiogenic potential

Abstract: Human mesenchymal stromal cell (hMSC) secretomes have shown to influence the microenvironment upon injury, promoting cytoprotection, angiogenesis, and tissue repair. The angiogenic potential is of particular interest for the treatment of ischemic diseases. Interestingly, hMSC secretomes isolated from different tissue sources have shown dissimilarities with respect to their angiogenic profile. This study compares angiogenesis of hMSC secretomes from adipose tissue (hADSCs), bone marrow (hBMSCs), and umbilical c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

8
120
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 165 publications
(138 citation statements)
references
References 43 publications
8
120
0
Order By: Relevance
“…This is in line with a previous study on cancer cells that clarified the increase in cell migration by delivery of some ECM molecules through exosomes [32]. In addition, the secretome from MSCs showed a positive effect on angiogenesis and chemotaxis of leukocytes [33]. However, further work is needed to characterize the protein and miRNA profile of the exosomes from the pulp to better understand the underlying mechanisms.…”
Section: Discussionsupporting
confidence: 85%
“…This is in line with a previous study on cancer cells that clarified the increase in cell migration by delivery of some ECM molecules through exosomes [32]. In addition, the secretome from MSCs showed a positive effect on angiogenesis and chemotaxis of leukocytes [33]. However, further work is needed to characterize the protein and miRNA profile of the exosomes from the pulp to better understand the underlying mechanisms.…”
Section: Discussionsupporting
confidence: 85%
“…Despite UCMSCs having similar PDTs between conditions, hypoxia is still worth exploring as animal studies have shown that UCMSCs, grown in hypoxia, have a higher angiogenic potential in the treatment of mouse hindlimb ischaemia [33,34] and rat spinal cord injury in comparison to UCMSCs grown in normoxia [35]. Indeed, the pro-angiogenic protein VEGF-A [36][37][38], was expressed in all conditions but upregulated in hypoxic/primed EV samples. VEGF-A is a well-documented hypoxic-induced response [39], there might be other hypoxic related changes in the EVs that weren't detected in this array; an array covering a broader repertoire of proteins might have identified more hypoxic-mediated changes.…”
Section: Discussionmentioning
confidence: 99%
“…Our recent work has demonstrated the secretome of BM‐MSCs can act as a biotherapeutic agent to stimulate murine pancreatic islet regeneration in vivo independent of cell transplantation . It remains to be determined whether a functionally “therapeutic” secretome is uniform across MSCs from different tissue sources, as the protein composition of an MSC‐generated secretome appears tissue‐specific . The advancement of human islet transplantation has generated cadaveric pancreatic tissue distribution centers, such as Integrated Islet Distribution Program (IIDP), that provide a reliable source of demographically diverse pancreatic tissue that may be used to establish MSC colonies from a previously unattainable source.…”
Section: Introductionmentioning
confidence: 99%